Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 51.7 CHF 0.98%
Market Cap: 702.9m CHF
Have any thoughts about
Medartis Holding AG?
Write Note
Section:
 

Relative Value

The Relative Value of one MED stock under the Base Case scenario is 99.96 CHF. Compared to the current market price of 51.7 CHF, Medartis Holding AG is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MED Relative Value
Base Case
99.96 CHF
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
96
vs Industry
31
Median 3Y
4.8
Median 5Y
4.6
Industry
2.3
Forward
2.8
More Details
172.5
P/E
P/E
Price to Earnings
172.5
vs History
33
vs Industry
0
Median 3Y
121.3
Median 5Y
105.6
Industry
23.1
Forward
65.8
More Details
21.6
P/OCF
P/OCF
Price to OCF
21.6
vs History
79
vs Industry
8
Median 3Y
45
Median 5Y
52.9
Industry
14.2
More Details
5.8
P/FCFE
P/FCFE
Price to FCFE
5.8
vs History
26
vs Industry
0
Median 3Y
-31.1
Median 5Y
-31.9
Industry
20.1
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
71
vs Industry
24
Median 3Y
3.8
Median 5Y
3.6
Industry
2.2
More Details
3.1
EV/S
EV/S
Enterprise Value to Sales
3.1
vs History
88
vs Industry
28
Median 3Y
5
Median 5Y
4.7
Industry
2.4
Forward
2.8
More Details
3.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.8
vs History
80
vs Industry
41
Median 3Y
6.2
Median 5Y
5.8
Industry
5
More Details
20.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.7
vs History
88
vs Industry
11
Median 3Y
43.3
Median 5Y
35
Industry
12.7
Forward
17.5
More Details
71.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
71.1
vs History
65
vs Industry
3
Median 3Y
95.5
Median 5Y
103.5
Industry
17.1
Forward
43.2
More Details
21.2
EV/OCF
EV/OCF
Enterprise Value to OCF
21.2
vs History
79
vs Industry
8
Median 3Y
45.5
Median 5Y
47.9
Industry
14
More Details
44.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
44.8
vs History
36
vs Industry
0
Median 3Y
49.1
Median 5Y
-38.3
Industry
18
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
92
vs Industry
29
Median 3Y
3.1
Median 5Y
2.9
Industry
1.9
More Details

Multiples Across Competitors

MED Competitors Multiples
Medartis Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Medartis Holding AG
SIX:MED
695.3m CHF 3.2 172.5 20.7 71.1
JP
Hoya Corp
TSE:7741
6.8T JPY 8.7 35.8 23.7 28.7
CH
Alcon AG
SIX:ALC
37.4B CHF 4.3 36 17.7 34.3
DK
Coloplast A/S
CSE:COLO B
179.5B DKK 6.6 35.5 22.9 26.9
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD 4 35.7 18 21.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52B CNY 11.7 28.1 24.4 24.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.4 -17.2 16.7 55.8
KR
HLB Inc
KOSDAQ:028300
9.1T KRW 175.4 -49 -75.4 -71.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD 4.1 14.5 10 11.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.7 23.8 39
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.2 264.5 462.1
P/E Multiple
Earnings Growth P/E to Growth
CH
Medartis Holding AG
SIX:MED
Average P/E: 49.2
172.5
3 491%
0
JP
Hoya Corp
TSE:7741
35.8
52%
0.7
CH
Alcon AG
SIX:ALC
36
107%
0.3
DK
Coloplast A/S
CSE:COLO B
35.5
50%
0.7
US
Align Technology Inc
NASDAQ:ALGN
35.7
102%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.1
92%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.2 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -49 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.5
69%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.7
159%
0.3
UK
ConvaTec Group PLC
LSE:CTEC
37.2
208%
0.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Medartis Holding AG
SIX:MED
Average EV/EBITDA: 44.2
20.7
86%
0.2
JP
Hoya Corp
TSE:7741
23.7
51%
0.5
CH
Alcon AG
SIX:ALC
17.7
34%
0.5
DK
Coloplast A/S
CSE:COLO B
22.9
39%
0.6
US
Align Technology Inc
NASDAQ:ALGN
18
52%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.4
103%
0.2
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
82%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -75.4 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10
43%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.8
81%
0.3
UK
ConvaTec Group PLC
LSE:CTEC
264.5
42%
6.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Medartis Holding AG
SIX:MED
Average EV/EBIT: 77.5
71.1
229%
0.3
JP
Hoya Corp
TSE:7741
28.7
N/A N/A
CH
Alcon AG
SIX:ALC
34.3
107%
0.3
DK
Coloplast A/S
CSE:COLO B
26.9
42%
0.6
US
Align Technology Inc
NASDAQ:ALGN
21.7
58%
0.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.4
87%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
55.8
283%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -71.1 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.3
47%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
39
148%
0.3
UK
ConvaTec Group PLC
LSE:CTEC
462.1
96%
4.8

See Also

Summary
MED intrinsic value, competitors valuation, and company profile.
DCF Valuation
MED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MED stock valuation using valuation multiples.
Wall Street Estimates
MED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.